Russell inclusion is coming folks. It's unavoidable and hedgies will begin picking up "cheap" shares to sell to the Russell funds at a nice premium. This years run will be an easy double in advance of the time the Russell buy-in date has arrived. Play this Russell, then sell half your shares if you're scared of the clinical results that will arrive in the near-term following Russell inclusion to avoid any downside. However if the news is right on as expected, then it's going to be "double the fun." 24 bucks a share in the 3rd quarter is very possible with positive results from the CF and/or NTM trial.
pianoman
Sentiment: Strong Buy